The Role of Lymphadenectomy in the Surgical Treatment of Esophageal and Gastric Cancer

Current Problems in Surgery

Volumn 49, Issue 8, 2012, Pages 471-515

  Vallbohmer, Daniel ^a   Oh, Daniel S ^b   Peters, Jeffrey H ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CERVICAL LYMPH NODE; DISEASE FREE SURVIVAL; DYSPHAGIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; GASTRECTOMY; GASTROINTESTINAL ENDOSCOPY; HUMAN; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; MEDIASTINUM LYMPH NODE; MICROMETASTASIS; MORTALITY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PANCREAS RESECTION; PATIENT SELECTION; RECURRENCE FREE SURVIVAL; SENTINEL LYMPH NODE; SPLENECTOMY; STOMACH CANCER; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR RECURRENCE;

ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; GASTRECTOMY; HISTORY, 15TH CENTURY; HISTORY, 16TH CENTURY; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MEDICAL ONCOLOGY; PATIENT SELECTION; SENTINEL LYMPH NODE BIOPSY; STOMACH NEOPLASMS;

EID: 84863829508     PISSN: 00113840     EISSN: 15356337     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2012.04.003     Document Type: Article

References (94)

1. Ballantyne G.H. Theories of carcinogenesis and their impact on surgical treatment of colorectal cancer: a historical review. Dis Colon Rectum 1988, 31:513-517.
2. Hunter J. A treatise on the blood, inflammation, and gun-shot wounds. London: J Richardson, 1794:5-86.
3. Bignold L.P., Coghlan B.L., Jersmann H.P.A. Cancer morphology, carcinogenesis and genetic instability: a background. Cancer: cell structures, carcinogens and genomic instability. EXS 2006, (96):1-24.
4. Moynihan B.G.A. The surgical treatment of cancer of the sigmoid flexure and rectum. Surg Gynecol Obstet 1908, 6:463-466.
5. McNeer G., Sunderland D.A., McInnes G., et al. A more thorough operation for gastric cancer: anatomical basis and description of technique. Cancer 1951, 4:957-967.
6. DiSiena M.R., Taneja C., Wanebo H.J. Radical gastrectomy and lymphadenectomy: historic overview, surgical trends, and lessons from the past. Surg Oncol Clin N Am 2005, 14:511-532.
7. Logan A. The surgical treatment of carcinoma of the esophagus and cardia. J Thorac Cardiovasc Surg 1963, 46:150-161.
8. Fisher B. Lymph node metastases-indicators, but not governors of survival. Arch Surg 1984, 119:1067-1072.
9. Williams V.A., Peters J.H. Adenocarcinoma of the gastroesophageal junction: benefits of an extended lymphadenectomy. Surg Clin N Am 2006, 15:765-780.
10. Hagen J.A., DeMeester S.R., Peters J.H., et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 2001, 234(4):520-530.
11. Ludwig J. On bypasses of the lymphatic system and their relations to lymphogenic cancer metastasis. Pathol Microbiol 1962, 25:329-334.
12. Zeidman I., Buss J.M. Transpulmonary passage of tumour cell emboli. Cancer Res 1952, 12:731-737.
13. Natarajan S., Taneja C., Cady B. Evolution of lymphadenectomy in surgical oncology. Surg Oncol Clin N Am 2005, 14:447-459.
14. Swanson S.J., Batirel H.F., Bueno R., et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 2001, 72:1918-1924.
15. Putnam J.B., Suell D.M., McMurtrey M.J., et al. Comparison of three techniques of esophagectomy within a residency training program. Ann Thorac Surg 1994, 57:319-325.
16. Horstmann O., Verreet P.R., Becker H., et al. Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer. Eur J Surg 1995, 161:557-567.
17. Altorki N.K., Girardi L., Skinner D.B. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg 1997, 114:948-955.
18. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002, 347:1662-1669.
19. Sihvo E.I., Luostarinen, Salo J.A. Fate of patients with adenocarcinoma of the esophagus and the esophagogastric junction: a population-based analysis. Am J Gastroenterol 2004, 99:419-424.
20. Orringer M.B., Marshall B., Stirling M.C. Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg 1993, 105:265-276.
21. Rentz J., Bull D., Harpole D., et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg 2003, 125:1114-1120.
22. Nigro J.J., Hagen J.A., DeMeester T.R., et al. Occult esophageal adenocarcinoma-extent of disease and implications for effective therapy. Ann Surg 1999, 230:433-440.
23. Nigro J.J., Hagen J.A., DeMeester T.R., et al. Prevalence and location of nodal metastasis in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999, 117:16-25.
24. Clark G.W., Peters J.H., Ireland A.P., et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994, 58:646-653.
25. Feith M., Stein H.J., Siewert J.R. Pattern of lymphatic spread of Barrett's cancer. World J Surg 2003, 27:1052-1057.
26. DeMeester T.R. Esophageal carcinoma: current controversies. Semin Surg Oncol 1997, 13:217-233.
27. Liebermann-Meffert D. Anatomical basis for the approach and extent of surgical treatment of esophageal cancer. Dis Esophagus 2001, 14:81-84.
28. Hosch S.B., Stoecklein N.H., Pichlmeier U., et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 2001, 19:1970-1975.
29. Rice T.W., Zuccaro G., Adelstein D.J., et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 1998, 65:787-792.
30. Akiyama H., Tsurumaru M., Udagawa H., et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994, 220:364-373.
31. Baba M., Aikou T., Yoshinaka H., et al. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994, 219:310-316.
32. Matsubara J., Ueda M., Yanagida O., et al. How extensive should lymph node dissection be for cancer of the thoracic esophagus?. J Thorac Cardiovasc Surg 1994, 107:1073-1078.
33. Lerut T., Nafteux P., Moons J., et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004, 240:962-974.
34. Altorki N., Kent M., Ferrara C., et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002, 236:177-183.
35. van de Ven C., De Leyn P., Coosemans W., et al. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg 1999, 15(6):769-773.
36. Ando N., Ozawa S., Kitagawa Y., et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000, 232:225-232.
37. Hulscher J.B.F., van Sandick J.W., Offerhaus G.J.A., et al. Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the esophagus or gastric cardia. Br J Surg 2001, 88:715-719.
38. Nishimaki T., Tanaka O., Sukuzi T., et al. Patterns of lymphatic spread in thoracic esophageal cancer. Cancer 1994, 74:4-11.
39. Dresner S.M., Lamb P.J., Bennett M.K., et al. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001, 129:103-109.
40. Kosaka T., Ueshige N., Sugaya J., et al. Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg Today 1999, 29:695-700.
41. Maruyama K., Gunvén P., Okabayashi K., et al. Lymph node metastases of gastric cancer. Ann Surg 1989, 210:596-602.
42. Japanese classification of gastric cancer-2nd English edition. Gastric Cancer 1998, 1:10-24. Japanese Gastric Cancer Association.
43. Johansson J.J., DeMeester T.R., Hagen J.A., et al. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg 2004, 139:627-633.
44. Altorki N., Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg 2001, 234:581-587.
45. Collard J.M., Otte J.B., Fiasse R., et al. Skeletonizing en bloc esophagectomy for cancer. Ann Surg 2001, 234:25-32.
46. Hulscher J.B., van Sandick J.W., Tijssen J.G., et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 2000, 191:143-148.
47. Becker C.D., Barbier P.A., Terrier F., et al. Patterns of recurrence of esophageal carcinoma after transhiatal esophagectomy and gastric interposition. Am J Roentgenol 1987, 148:273-277.
48. Gignoux M., Roussel A., Paillot B., et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 1987, 11:426-432.
49. Nygaard K., Hagen S., Hansen H.S., et al. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992, 16:1104-1109.
50. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002, 20:1167-1174.
51. Pennathur A., Zhang J., Chen H., et al. The "best operation" for esophageal cancer?. Ann Thorac Surg 2010, 89:S2163-S2167.
52. Gockel I., Sgourakis G., Lyros O., et al. Dissection of lymph node metastases in esophageal cancer. Expert Rev Anticancer Ther 2011, 11:571-578.
53. Morton D.L., Thompson J.F., Essner R., et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for earlystage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999, 230:453-463.
54. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998, 339:941-946.
55. Takeuchi H., Kitagawa Y. Sentinel node navigation surgery for esophageal cancer. Gen Thorac Cardiovasc Surg 2008, 56:393-396.
56. Takeuchi H., Fujii H., Ando N., et al. Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg 2009, 249:757-763.
57. Sgourakis G., Gockel I., Lyros O., et al. Detection of lymph node metastases in esophageal cancer. Expert Rev Anticancer Ther 2011, 11:601-612.
58. Thompson S.K., Bartholomeusz D., Devitt P.G., et al. Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy. Surg Endosc 2011, 25:817-825.
59. Guidelines for Diagnosis and Treatment of Carcinoma of the Stomach 2004, Japanese Gastric Cancer Society. 2nd edition.
60. Siewert J.R., Böttcher K., Stein H.J., et al. Relevant prognostic factors in gastric cancer: ten-year results of the German gastric cancer study. Ann Surg 1998, 228:449-461.
61. Moehler M., Al-Batran S.E., Andus T., et al. German S3-guideline "diagnosis and treatment of esophagogastric cancer.". Z Gastroenterol 2011, 49:461-531.
62. Kitagawa Y., Fujii H., Mukai M., et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 2000, 80:1799-1809.
63. Orsenigo E., Tomajer V., Di Palo S., et al. Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer. Surg Endosc 2008, 22:118-121.
64. Hundley J.C., Shen P., Shiver S.A., et al. Lymphatic mapping for gastric adenocarcinoma. Am Surg 2002, 68:931-935.
65. Ryu K.W., Lee J.H., Kim H.S., et al. Prediction of lymph nodes metastasis by sentinel node biopsy in gastric cancer. Eur J Surg Oncol 2003, 29:895-899.
66. Kitagawa Y., Fujii H., Kumai K., et al. Recent advances in sentinel node navigation for gastric cancer: a paradigm shift of surgical management. J Surg Oncol 2005, 90:147-151.
67. Lee J.H., Ryu K.W., Kook M.C., et al. Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer. J Surg Oncol 2008, 98:331-335.
68. Ichikura T., Sugasawa H., Sakamoto N., et al. Limited gastrectomy with dissection of sentinel node stations for early gastric cancer with negative sentinel node biopsy. Ann Surg 2009, 249:942-947.
69. Cozzaglio L., Bottura R., Di Rocco M., et al. Sentinel lymph node biopsy in gastric cancer: possible applications and limits. Eur J Surg Oncol 2011, 37:55-59.
70. Huang B., Wang Z., Sun Z., et al. A novel insight of sentinel lymph node concept based on 1-3 positive nodes in patients with pT1-2 gastric cancer. BMC Cancer 2011, 11:18.
71. Omloo J.M., Lagarde S.M., Hulscher J.B., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of mid/distal esophagus. Five-year survival of a randomized clinical trial. Ann Surg 2007, 246:992-1000.
72. Kang C.H., Kim Y.T., Jeon S.H., et al. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Eur J Cardiothorac Surg 2007, 31:154-160.
73. Schwarz R.E., Smith D.D. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg 2007, 11:1384-1393.
74. Altorki N.K., Zhou X.K., Stiles B., et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 2008, 248:221-226.
75. Greenstein A.J., Litle V.R., Swanson S.J., et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 2008, 112:1239-1246.
76. Peyre C.G., Hagen J.A., DeMeester S.R., et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 2008, 248:549-556.
77. Rizk N.P., Ishwaran H., Rice T.W., et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg 2010, 251:46-50.
78. Nishihara T., Hirayama K., Mori S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998, 175:47-51.
79. Shim Y.M., Kim H.K., Kim K. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma. J Thorac Oncol 2010, 5:707-712.
80. Bonenkamp J.J., Hermans J., Sasako M., et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999, 340:908-914.
81. Bonenkamp J.J., Songun I., Hermans J., et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995, 345:745-748.
82. Cuschieri A., Weeden S., Fielding J., et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999, 79:1522-1530.
83. Robertson C.S., Chung S.C., Woods S.D., et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994, 220:176-182.
84. Degiuli M., Sasako M., Calgaro M., et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomized surgical trial. Eur J Surg Oncol 2004, 30:303-308.
85. Wu C.W., Hsiung C.A., Lo S.S., et al. Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancet Oncol 2006, 7:309-315.
86. McCulloch P., Nita M.E., Kazi H., et al. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004, 4. CD001964.
87. Sano T., Sasako M., Yamamoto S., et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 2004, 22:2767-2773.
88. Kulig J., Popiela T., Kolodziejczyk P., et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 2007, 193:10-15.
89. Yonemura Y., Wu C.C., Fukushima N., et al. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepato Gastroenterol 2006, 53:389-394.
90. Yonemura Y., Wu C.C., Fukushima N., et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol 2008, 13:132-137.
91. Smith D.D., Schwarz R.R., Schwarz R.E. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 2005, 23:7114-7124.
92. Schwarz R.E., Smith D.D. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol 2007, 14:317-328.
93. Huang C.M., Lin J.X., Zheng C.H., et al. Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer. World J Gastroenterol 2009, 15:3926-3930.
94. Sano T., Yamamoto S., Sasako M., et al. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. Jpn J Clin Oncol 2002, 32:363-364.